Colocalization of phosphorylated PPARγ and active β-catenin was also identified in podocytes of DN samples (Figures 6h–j), further supporting the notion that PPARγ-mediated β-catenin activation promotes podocyte injury in DN. The gene discussed is PPARG; the disease is liver dysplastic nodule.